The study reconfirmed the association of the unveiled core genes, VPS53, SCGN, RGS6, SGCG, and FOXN3, with NAFLD and T2D, which had been reported in previous studies. The gene discussed is FOXN3; the disease is metabolic dysfunction-associated steatotic liver disease.